Skip to main content
OpenTrials
Completed

NCT Number: NCT03417596

Vestibular Rehabilitation in Patients With Vestibular Migraine

Abstract: Introduction:

Vestibular migraine(VM) is a disease that manifests with episodic vertigo attacks in patients with or without migraine type headaches, when present accompanying the headaches. Its prevalence was found out as %1 in a study in Germany. It usually involves middle aged women. VM can make a huge impact on quality of life, therefore advances in its diagnosis and management are valuable. While pharmacotherapy that is being used in migraine can be beneficial, vestibular rehabilitation(VR) programmes are predicted to be one of the most important types of treatment in management of VM. This study compares the results of pharmacological management options and vestibular rehabilitation programmes in the context of dizziness, balance problems and headache.

Material and methods:

77 patients with VM were included in study, and 60 of them completed it. While one group took only VR programme, and another took only pharmacological prophylaxis. The third group took a combined therapy, and the groups were consisted of 20 patients. Patients were assessed with caloric tests, audiometric studies, static posturography, Dizziness Handicap Inventory(DHI), and Activities Specific Balance Confidence(ABC) scales. All of the assessments were applied 3 times throughout the study, and the results were compared with relevant statistical tests.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1-Vestibular Migraine diagnosis according to International Classification of Headache Disorders (3 rd edition-Beta version) 2- No history of vestibular rehabilitation or exercises

Exclusion criteria

  • History of psychiatric disorder which might interfere with compliance to study
  • Other diagnosis that might possibly cause vestibular disorder(cerebellar disorders, Meniere disease etc)
  • Anatomical defects of the inner ear or vestibular system
  • Patients who are unable to stand up straight or walk

Treatment and study plan

Control

Other

Routine treatment

Vestibular rehabilitation

Behavioral

Exercise and rehabilitation programme was individualized

Primary outcomes

  1. Dizziness Handicap Inventory

    Time frame: 6 months

    A standardized inventory to assess the impact of dizziness in patients' life.

  2. Activities-specific balance confidence scale

    Time frame: 6 months

    A scale which is used to evaluate balance confidence of patients in some specific activities. Confidence in daily activities requiring balance is rated by subject as percentage(from %0 to %100). Higher percentage relates to better confidence in balance.

  3. Static Posturography

    Time frame: 6 months

    Static posturography was performed using the NeuroCom System Version 8.0.3 (NeuroCom International Inc., Clackamas, OR, USA). Mean center of gravity (COG) sway velocity (°/s) was recorded on a static platform with eyes open (ST-EO) and closed (ST-EC) and on foam with eyes open (FO-EO) and closed (FO-EC)

Secondary outcomes

  1. Vertigo attack severity

    Time frame: 6 months

    Self reported outcome in which patients give insight about their vertigo attack severity

Sponsors and collaborators

Lead sponsor

Ege University

Other

Registry information

Official study title

Efficacy of Vestibular Rehabilitation in Patients With Vestibular Migraine

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jan 31, 2018
Registry last updated
Jan 31, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.